114 related articles for article (PubMed ID: 10094885)
1. 99m-Tc-tetrofosmin scintigraphy and breast cancer.
Berghammer P; Obwegeser R; Mülauer-Ertl S; Karanikas G; Wiltschke C; Kubista E; Sinzinger H; Zielinski C
Gynecol Oncol; 1999 Apr; 73(1):87-90. PubMed ID: 10094885
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
3. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
5. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
6. The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer.
Fattori B; Grosso M; Nacci A; Bianchi F; Cosottini M; Ursino F; Manca G; Rubello D; Strauss HW; Mariani G
Cancer Biother Radiopharm; 2005 Feb; 20(1):27-35. PubMed ID: 15778576
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
9. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
[TBL] [Abstract][Full Text] [Related]
10. 99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions.
Obwegeser R; Berghammer P; Muellauer-Ertl S; Kubista E; Sinzinger H
Breast Cancer Res Treat; 2000 Aug; 62(3):253-8. PubMed ID: 11072790
[TBL] [Abstract][Full Text] [Related]
11. Detection of axillary lymph node metastases in breast cancer with Tc-99m tetrofosmin scintigraphy.
Schillaci O; Scopinaro F; Spanu A; Donnetti M; Danieli R; Di Luzio E; Madeddu G; David V
Int J Oncol; 2002 Mar; 20(3):483-7. PubMed ID: 11836558
[TBL] [Abstract][Full Text] [Related]
12. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
[TBL] [Abstract][Full Text] [Related]
14. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
15. A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions.
Obwegeser R; Berghammer P; Rodrigues M; Granegger S; Hohlagschwandtner M; Kucera H; Singer C; Berger A; Kubista E; Sinzinger H
Eur J Nucl Med; 1999 Dec; 26(12):1553-9. PubMed ID: 10638406
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of bone marrow accumulation of Tc-99m tetrofosmin for subsequent development of distant metastases in breast cancer.
Wakasugi S; Tsukuma H; Inaji H; Hashizume T; Noguchi A; Ohnishi T
Ann Nucl Med; 2007 Oct; 21(8):429-37. PubMed ID: 17952551
[TBL] [Abstract][Full Text] [Related]
18. [Detection of melanoma metastases with Tc-99m-tetrofosmin].
Rettenbacher L; Koller J; Kässmann H; Galvan G
Nuklearmedizin; 2000; 39(4):97-101. PubMed ID: 10919159
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences.
Spanu A; Farris A; Schillaci O; Chessa F; Solinas ME; Falchi A; Madeddu G; Nuvoli S; Madeddu G
Nucl Med Commun; 2003 Feb; 24(2):145-54. PubMed ID: 12548039
[TBL] [Abstract][Full Text] [Related]
20. The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection.
Spanu A; Tanda F; Dettori G; Manca A; Chessa F; Porcu A; Falchi A; Nuvoli S; Madeddu G
Q J Nucl Med; 2003 Jun; 47(2):116-28. PubMed ID: 12865872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
